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Background:  The Wriskwatch is a novel, watch-based pulse detection device that detects the loss of a radial pulse via advanced pulse detection 
technology and immediately contacts emergency medical systems with patient location information. 
Methods:  We designed a first in man, prospective, single-blinded, phase I study to evaluate the ability of this device to detect pulselessness in 
humans. Our cohort consisted of 34 patients: 24 hospitalized patients and 10 presenting for defibrillation threshold testing (DFT). We simulated 
loss of pulse in our hospitalized patients via blood pressure cuff inflation to occlude the brachial arterial pulse at random times in 20 subjects with 
no inflations in 4. Of the 10 patients undergoing DFT testing, the exact times of ventricular fibrillation induction were recorded. A blinded reviewer 
determined if and when the pulse was lost in all patients using only data from the device(figure shows typical signal gap). 
Results:  Of 34 patients, 2 had an unusable signal, 1 had device ejection during DFT testing, and 2 had too much motion artifact and were 
excluded. Of the 29 remaining subjects, 4 had no loss of pulse of which the device correctly identified 3. In the remaining 25 patients, the device 
correctly identified the time of pulselessness in 23 of 25 (16 of 17 hospitalized patients and 7 of 8 DFT patients). 
Conclusion: The Wriskwatch is a novel device that shows promise as a tool to hasten activation of emergency systems and facilitate early 
defibrillation in patients with cardiac arrest. 
